# K012066: Protege Self-Expanding Nitinol Stent with Starport Delivery Technology

- Pathway: 510(k) (Special)
- Applicant: Sulzer Intratherapeutics, Inc.
- Decided: Aug 1, 2001 after 30 days
- Product code: FGE (Stents, Drains And Dilators For The Biliary Ducts)
- Device class: 2
- Regulation: 21 CFR 876.5010
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K003040 (2000). 1 ancestor in all.
2 later devices descend from it; 2 cite it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K003040: Intrastent Protege Self-Expanding Nitinol Stent with Starport Delivery Technology, Intratherapeutics, Inc. (2000) Summary page 1.

## Most influential descendants
- K021729: Modification to Protege Self-Expanding Nitinol Stent with Starport Delivery Technology (2002), 0 descendants of its own
- K014136: Modification to Protege Self-Expanding Nitinol Stent with Starport Delivery Technology (2002), 0 descendants of its own

## Indications for use
The Protégé™ Self-Expanding Nitinol Stent with StarPort™ Delivery Technology (Biliary Indication) is intended as a palliative treatment of malignant neoplasms in the biliary tree.

Source page: https://510kreport.com/device/K012066
Methodology: https://510kreport.com/methodology